Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects
Phase 1
Recruiting
- Conditions
- NASH
- Interventions
- Drug: BAR502 single doseDrug: Placebo single doseDrug: BAR502 multiple doses
- First Posted Date
- 2024-11-26
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- BAR Pharmaceuticals s.r.l.
- Target Recruit Count
- 52
- Registration Number
- NCT06705998
- Locations
- 🇨🇭
CROSS Research S.A. Phase I Unit, Arzo, Switzerland
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- BAR Pharmaceuticals s.r.l.
- Registration Number
- NCT05203367
- Locations
- 🇵🇹
BlueClinical Phase I, Porto, Portugal
News
No news found